Literature DB >> 16849419

Intronic deletions in the SLC34A3 gene cause hereditary hypophosphatemic rickets with hypercalciuria.

Shoji Ichikawa1, Andrea H Sorenson, Erik A Imel, Nancy E Friedman, Joseph M Gertner, Michael J Econs.   

Abstract

CONTEXT: Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) is a rare metabolic disorder, characterized by hypophosphatemia and rickets/osteomalacia with increased serum 1,25-dihydroxyvitamin D [1,25-(OH)(2)D] resulting in hypercalciuria.
OBJECTIVE: Our objective was to determine whether mutations in the SLC34A3 gene, which encodes sodium-phosphate cotransporter type IIc, are responsible for the occurrence of HHRH. DESIGN AND
SETTING: Mutation analysis of exons and adjacent introns in the SLC34A3 gene was conducted at an academic research laboratory and medical center. PATIENTS OR OTHER PARTICIPANTS: Members of two unrelated families with HHRH participated in the study.
RESULTS: Two affected siblings in one family were homozygous for a 101-bp deletion in intron 9. Haplotype analysis of the SLC34A3 locus in the family showed that the two deletions are on different haplotypes. An unrelated individual with HHRH was a compound heterozygote for an 85-bp deletion in intron 10 and a G-to-A substitution at the last nucleotide in exon 7. The intron 9 deletion (and likely the other two mutations) identified in this study causes aberrant RNA splicing. Sequence analysis of the deleted regions revealed the presence of direct repeats of homologous sequences.
CONCLUSION: HHRH is caused by biallelic mutations in the SLC34A3 gene. Haplotype analysis suggests that the two intron 9 deletions arose independently. The identification of three independent deletions in introns 9 and 10 suggests that the SLC34A3 gene may be susceptible to unequal crossing over because of sequence misalignment during meiosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849419     DOI: 10.1210/jc.2005-2840

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  52 in total

1.  Novel NaPi-IIc mutations causing HHRH and idiopathic hypercalciuria in several unrelated families: long-term follow-up in one kindred.

Authors:  Y Yu; S R Sanderson; M Reyes; A Sharma; N Dunbar; T Srivastava; H Jüppner; C Bergwitz
Journal:  Bone       Date:  2012-02-24       Impact factor: 4.398

Review 2.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

3.  Acute down-regulation of sodium-dependent phosphate transporter NPT2a involves predominantly the cAMP/PKA pathway as revealed by signaling-selective parathyroid hormone analogs.

Authors:  So Nagai; Makoto Okazaki; Hiroko Segawa; Clemens Bergwitz; Thomas Dean; John T Potts; Matthew J Mahon; Thomas J Gardella; Harald Jüppner
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

4.  Expression of renal and intestinal Na/Pi cotransporters in the absence of GABARAP.

Authors:  Sonja C Reining; Annette Liesegang; Heinrich Betz; Jürg Biber; Heini Murer; Nati Hernando
Journal:  Pflugers Arch       Date:  2010-03-31       Impact factor: 3.657

5.  Intronic deletions in the SLC34A3 gene: a cautionary tale for mutation analysis of hereditary hypophosphatemic rickets with hypercalciuria.

Authors:  Shoji Ichikawa; Shamir Tuchman; Leah R Padgett; Amie K Gray; H Jorge Baluarte; Michael J Econs
Journal:  Bone       Date:  2013-10-29       Impact factor: 4.398

Review 6.  What is nephrocalcinosis?

Authors:  Linda Shavit; Philippe Jaeger; Robert J Unwin
Journal:  Kidney Int       Date:  2015-03-25       Impact factor: 10.612

Review 7.  Expression and function of Slc34 sodium-phosphate co-transporters in skeleton and teeth.

Authors:  Laurent Beck
Journal:  Pflugers Arch       Date:  2018-12-03       Impact factor: 3.657

8.  A patient with hypophosphatemia, a femoral fracture, and recurrent kidney stones: report of a novel mutation in SLC34A3.

Authors:  Kathleen Page; Clemens Bergwitz; Graciana Jaureguiberry; Chittari V Harinarayan; Karl Insogna
Journal:  Endocr Pract       Date:  2008-10       Impact factor: 3.443

9.  Type IIc sodium-dependent phosphate transporter regulates calcium metabolism.

Authors:  Hiroko Segawa; Akemi Onitsuka; Masashi Kuwahata; Etsuyo Hanabusa; Junya Furutani; Ichiro Kaneko; Yuka Tomoe; Fumito Aranami; Natsuki Matsumoto; Mikiko Ito; Mitsuru Matsumoto; Minqi Li; Norio Amizuka; Ken-Ichi Miyamoto
Journal:  J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 10.121

10.  Differential regulation of the renal sodium-phosphate cotransporters NaPi-IIa, NaPi-IIc, and PiT-2 in dietary potassium deficiency.

Authors:  Sophia Y Breusegem; Hideaki Takahashi; Hector Giral-Arnal; Xiaoxin Wang; Tao Jiang; Jill W Verlander; Paul Wilson; Shinobu Miyazaki-Anzai; Eileen Sutherland; Yupanqui Caldas; Judith T Blaine; Hiroko Segawa; Ken-ichi Miyamoto; Nicholas P Barry; Moshe Levi
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.